C-dots generate ROS under photoactivation, enabling photodynamic disruption of biofilms while minimizing systemic effects [72, 73]
In summary: BPC-157 is a promising compound for different cytoprotective uses It is not FDA approved for human use There is not some shadow cabal blocking the use of BPC-157 - Financial incentives make it so that BPC-157 is challenging to push through the regulatory process - It will likely never receive FDA approval, but will be available in some form as oral supplement or through compounding pharmacies, with some modification This is not medical advice
Always verify the vial strength, reconstitution amount, prescribed dose, injection frequency, syringe type, and measurement instructions before administering medication
This is a developing area of study, but it aligns with real-world reports of improved mobility and comfort during weight loss
Berzuini A, Bianco C, Paccapelo C, Bertolini F, Gregato G, Cattaneo A, et al
Dose escalation raises the price on most programs, so the $199 starting month is not the steady-state number once you reach a maintenance dose